BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Finance
Atox Bio Locks In $23 Million 7/24/2014
Xention Limited Awarded £1.4m From Technology Strategy Board To Develop New Medicines For Atrial Fibrillation 7/24/2014
Mela Sciences (MELA) Announces $27.3 Million Private Placement Of Preferred Stock, Debentures And Warrants 7/23/2014
Cambridge-Based Broad Institute To Receive Largest Gift Worldwide: $650 Million 7/23/2014
Taiho Pharmaceutical Invests US $30 Million In Remiges Biopharma Fund, LP 7/23/2014
Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture 7/22/2014
Skystar Bio-Pharmaceutical (CGPN) Of Xi’an Raises $5 Million 7/22/2014
StemCells Inc. (STEM) Announces Closing Of $20 Million Offering 7/21/2014
Phosphagenics Limited (POH.AX) Completes First Tranche of A $19.3 Million Capital Raising 7/21/2014
Cerecor Inc. Closes On Initial Tranche Of US $32 Million Series B Financing 7/21/2014
UrgentRx® Locks In $17.5 Million In Series C Funding 7/17/2014
Infosys Co-founder Kris Gopalakrishnan Donates $1.8 Million To Carnegie Mellon University To Promote Brain Research And Education 7/17/2014
InflaRx Announces Successful Closing Of Its Round B Financing 7/17/2014
Melanoma Research Foundation Release: Senate Appropriations Committee Increases Funding Available For Melanoma Research 7/17/2014
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014
Menlo Park's Virobay Inc. Completes $8 Million Series B Funding Round 7/16/2014
immatics biotechnologies GmbH Reels In €22 Million Series D 7/16/2014
Virobay Inc. Completes $8 Million Series B Preferred Stock Financing 7/16/2014
Phosphagenics Limited (POH.AX) Locks In $19.3 Million Capital Raising 7/11/2014
TONIX Pharmaceuticals, Inc. Announces Registered Direct Offering Of $7.8 Million 7/11/2014
Ocera Therapeutics, Inc. (OCRX) Raises $25.2 Million In Public Offering 7/10/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
VC Firm Versant Ventures Closes In On $300 Million Fund For Medtech And Biotech 7/9/2014
National Institutes of Health (NIH) Funds Phase 2 Clinical Trial At University of California, Los Angeles (UCLA) For The Treatment Of ADHD With NeuroSigma, Inc.'s eTNS Systemnational 7/9/2014
DelMar Pharmaceuticals Receives Funding From The Canadian Federal Government 7/9/2014
MabVax Therapeutics, Inc. Raises $3 Million In Common Stock Financing And An Additional $1.5 Million Upon Exercise Of Series C-1 Warrants 7/9/2014
480 Biomedical Awarded $1 Million Phase II NHLBI Contract To Advance Bioresorbable Scaffold For Pediatric Pulmonary Artery Stenosis 7/9/2014
Chromatin, Inc.Secures $12.5 Million Credit Facility With The PrivateBank 7/9/2014
Biosceptre International Limited Closes AUD 5 Million Financing From Existing Investors 7/9/2014
Domainex Ltd Reports Success Of Its Lead Compound In Pre-Clinical Model Of COPD And Secures £1.4 Million Biomedical Catalyst Award 7/9/2014
Supernus Pharmaceuticals (SUPN) To Receive $30 Million In Non-Dilutive Royalty Deal 7/8/2014
National Institutes of Health (NIH) Has A New $248 Million Focus: Electroceuticals 7/7/2014
New York Couple Gifts Cold Spring Harbor Laboratory $50 Million For Biology Center 7/7/2014
Galapagos NV (GLPG.BR) Raises €1.9 Million Through Warrant Exercises 7/7/2014
ProSensa Holding N.V. (RNA) Files F-3 SEC Mixed Shelf Registration For Up To $150 Million 7/7/2014
Zurex Pharma, Inc. Nabs $4 Million to Battle Hospital-Acquired Infections 7/3/2014
Advanced Cell Technology Secures $30 Million Financing 7/3/2014
Akashi Therapeutics Receives Collective Funding Of $1.5 Million To Support HT-100 Clinical Development 7/3/2014
Retrophin, Inc. (RTRX) Snags $91 Million 7/2/2014
Novato's Raptor Pharmaceutical Inc. (RPTP) Reels In $70 Million 7/2/2014
Massachusetts Startup Synchroneuron Nets $20 Million To Fund SNC-102 For Neuropsychiatric Disorders 7/2/2014
Oxford Finance and Solar Capital Close $30 Million Senior Debt Facility With Radius (RDUS) 7/2/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
Menlo Park's Emerald Therapeutics Completes Latest Financing, Brings Total To $13.5 Million 7/1/2014
South San Francisco's Tobira Therapeutics Inc. Wraps Up $15 Million Loan Agreement 7/1/2014
TrovaGene, Inc. Secures $15 Million In Debt Financing From Trojantec Ltd. And Oxford Finance 7/1/2014
Sorrento Therapeutics, Inc. Awarded Up To $2.6 Million From The National Institutes of Health (NIH) For The Development Of New Anti-Bacterial Bispecific Antibodies And Antibody Formulated Drug Conjugates 7/1/2014
Karo Bio AB Granted 3.8 MSEK From Vinnova 7/1/2014
uniQure Secures Additional $10 Million Venture Loan From Hercules Capital 7/1/2014
Confirmed: With $32 Million, Boston Startup Morphs Into San Diego's Cidara Therapeutics 7/1/2014
Shire Gets $248 Million Tax Refund From Canada, More To Come 6/30/2014
To-BBB technologies BV Scrounges Up Euro 10 Million 6/30/2014
SiEnergy Systems, LLC Awarded $2.65 Million As Part Of ARPA-E’s REBELS Program To Develop Innovative Distributed Generation Technologies 6/27/2014
DURECT Corporation (DRRX) Secures $20 Million Debt Financing 6/27/2014
Biotech-Focused VC Firm Polaris Targets $400 Million For 7th Fund 6/27/2014
Actavis (ACT) Dumps $18 Million In New Warehouse Facilities 6/27/2014
Eighteen French Biotechs Such As Genticel And Genomic Vision Trek To New York To Hunt For American Investors 6/26/2014
Cytomedix Inc. (CMXI) Completes The Second Tranche Of The $35 Million Convertible Debt Financing With Deerfield Management Company 6/26/2014
Manchester's 4D Pharma Reels In $29 Million 6/26/2014
Biotech Fraud-Detection Firm BioCatch Bags $10 Million In Funding 6/26/2014
HedgePath Pharmaceuticals Secures Interim Financing To Commence Clinical Trials And Finalizes Key Agreement With Mayne Pharma Limited 6/25/2014
CrystalGenomics Nabs $12.8 Million From The Global Pharmaceutical Industry Development Fund 6/25/2014
Backed By New Investors Such As Lilly Ventures, Bay Area's Numerate Secures $8 Million 6/24/2014
TetraLogic Pharmaceuticals (TLOG) Announces Closing Of $47 Million Convertible Senior Notes Offering 6/24/2014
Transition Therapeutics Inc. (TTH.TO) Announces Closing Of Private Placement Equity Financing 6/23/2014
Oxitec Completes Oversubscribed £6.1 Million ($10.2 Million) Fundraising To Commercialise Pioneering Dengue Mosquito Control Technology 6/23/2014
Cambridge Startup Dimension Therapeutics Reels In $30 Million Financing 6/23/2014
Los Angeles' Genzum Life Sciences Reels In $20 Million In Funding 6/20/2014
Cambridge Startup Navitor Pharmaceuticals Debuts With $23.5 Million Series A In Pocket 6/20/2014
Dr. Reddy's Laboratories Ltd. (RDY) To Dump $320 Million In Biologics, Proprietary Medicines 6/20/2014
Sidney Kimmel Foundation Gives $110 Million To Jefferson Medical College Of Thomas Jefferson University 6/19/2014
Tyrogenex, Inc. Nabs $15 Million Series D Financing 6/19/2014
JHL Biotech Locks In $35 Million Series B Financing 6/19/2014
Horizon Biopharm In $300 Million Credit Agreement For Vidara Therapeutics Buy 6/19/2014
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $47 Million Offering Of Convertible Notes 6/18/2014
Lakewood-Amedex Inc. Raises $5.5 Million In Series C Preferred Stock Financing 6/18/2014
Valeant Pharmaceuticals International (VRX) Commences Exchange Offer For Allergan Inc. (AGN) 6/18/2014
Western Oncolytics Receives $275,000 Seed Funding For Development Of Cancer Immunotherapy 6/18/2014
South San Francisco's True North Therapeutics Reels In $22 Million Series A Financing 6/18/2014
AuraSense Therapeutics Completes $13.6 Million Series C Equity Investment 6/17/2014
BioTime (BTX) Subsidiary Asterias Biotherapeutics Announces Investment By CEO 6/17/2014
BioTime (BTX) Subsidiary Asterias Biotherapeutics Raises $13.0 Million In Equity Financing 6/17/2014
Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million In Connection With Going Public Transaction 6/16/2014
BrainStorm Cell Therapeutics Inc. Raises $10.5 Million In Private Placement Financing 6/13/2014
CannLabs, Announces Reverse Merger And Commitment Of $1.25 Million In Funding 6/13/2014
Berkeley's Aduro Biotech Reels In $55 Million Series C Financing 6/13/2014
Health Integrated Secures $4 Million In Venture Debt Financing From Western Technology Investment 6/12/2014
Cortexyme Raises Seed Funding, Awarded Breakout Labs Investment 6/12/2014
Clarus Therapeutics Locks In $31.5 Million 6/12/2014
Merus Labs International Inc. Announces Aggregate $21 Million Financing Transactions 6/11/2014
BioSilta Completes EUR 2.5 Million ($3.4 Million) Funding Round 6/11/2014
Oxford Finance Closes $4 Million Debt Facility With IntelliCyt Corporation 6/11/2014
RuiYi (formerly Anaphore) Closes $4 Million Venture Loan From Silicon Valley Bank 6/11/2014
As Its Investors Reap Returns, San Francisco's Venbio Aims For A Bigger Second Fund 6/10/2014
Cytori Therapeutics, Inc. (CYTX) Closes Previously Announced $10 Million Offering 6/6/2014
Transition Therapeutics Inc. (TTH.TO) Enters Into Deal With Investors To Receive Up To $30.8 Million 6/6/2014
Nordic Nanovector Intends To Undertake Private Placement Of NOK 150 Million 6/6/2014
Its First Drug In Clinic, Kineta Inc. Keeps Raising Cash From Odd Sources 6/5/2014
“Grindeks” Invests 2.4 Million Euros In Quality Control Laboratory 6/5/2014
Complexa Wraps Up $13 Million Series B Financing Round 6/4/2014
SteadyMed Announces Raise Of $19.6 Million In Preferred Stock Financing 6/4/2014
Clinical Stage Biotech Trevi Therapeutics Brings In $25 Million Series B Financing 6/4/2014
KemPharm, Inc. Bags $60 Million 6/3/2014
Nanotherapeutics Secures $30 Million Loan 6/3/2014
NeoStem, Inc. Accesses $30 Million Equity Facility With Aspire Capital 6/3/2014
Nuvilex (NVLX) Now Has Access To $50 Million With New Banking Agreement 6/2/2014
DefiniGEN Announces Closing Of £2.3 Million ($3.8 Million) Series A Fundraising 6/2/2014
Relypsa, Inc. (RLYP) Secures Loan Facility Of Up To $35 Million 6/2/2014
Jubilant Pharma To Raise Over $100 Million, Plans To Consolidate Pharma Biz 6/2/2014
Retrophin, Inc. (RTRX) Signs A $80 Million Term Loan And Convertible Note Issuing 5/30/2014
Cambridge-Based Biotech Rodin Therapeutics Snags $12.9 Million Series A Financing 5/30/2014
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Establishes 3.0 Million Share Equity Line 5/30/2014
Cytori Therapeutics, Inc. (CYTX) To Raise $10 Million In Registered Direct Offering 5/30/2014
VC Firm Epidarex Capital Unveils £47.5 Fund For Early-Stage UK Startups, Spinouts 5/29/2014
Evoke Pharma, Inc. Secures $4.5 Million Loan Facility With Square 1 Bank 5/29/2014
Tarsa Therapeutics Reels In $7 Million To Prepare For Filing NDA For Ostora 5/29/2014
Redwood City Biotech ARMO BioSciences Locks Down $30 Million Series B 5/29/2014
Children's Hospital of Philadelphia Gene-Therapy Spinout Spark Therapeutics Hauls In $72.8 Million 5/29/2014
Bay Area's Twist Bioscience Secures $31.1 Million 5/28/2014
San Francisco Biotech Startup Nurix Taps $25.1 Million Financing 5/27/2014
OXiGENE (OXGN) Announces $16 Million At-The-Market Registered Direct Offering 5/23/2014
Crown Bioscience, Inc. Raises $26.6 Million In Series D Round 5/23/2014
Mucosis B.V. Receives Financial Support From The Dutch Government For Its Syngem® Program 5/22/2014
Lanthio Pharma Receives Dutch Government Loan Of Up To €3.6 Million To Develop Novel Therapy For Lung Fibrosis 5/21/2014
Roche (RHHBY) To Invest $135 Million Into Two New Manufacturing Facilities 5/21/2014
Gene Therapy Biotech Lysogene Reels In $22 Million 5/21/2014
Landmark Gift Of $100 Million From The Marie-Josée And Henry R. Kravis Foundation Will Support Groundbreaking Approach To Precision Oncology At Memorial Sloan-Kettering Cancer Center 5/20/2014
Redwood City's Coherus Biosciences Locks In $55 Million Series C 5/20/2014
Chimerix, Inc. (CMRX) Looks To Rally Up $60 Million Partly To Pay For Drug Trial With Josh Hardy 5/20/2014
AmerisourceBergen Corporation (ABC) Okays Special $650 Million Special Share Repurchase Program 5/19/2014
Proteon Therapeutics, Inc. Announces $45 Million Of Series D Financing 5/16/2014
Gelesis Expands Team To Advance Further Clinical Development Of Its Novel Obesity & Diabetes Therapy & Discloses Recent $12 Million Funding 5/16/2014
Kymab Locks Down $40 Million For Antibody Research 5/16/2014
Sorbent Therapeutics, Inc. Closes $15 Million In First Tranche Of Series D 5/15/2014
Milestone Scientific (MS) Completes $10 Million Financing With A European Investing Group Specializing In High Potential Opportunities 5/15/2014
Xellia Pharmaceuticals Expands Croatian Product And Innovation R&D Center Of Excellence With Investment Of US$2.0 Million 5/14/2014
Transcept Pharmaceuticals, Inc. (TSPT) Declares Special Cash Dividend Of $25 Million 5/14/2014
Chase Pharmaceuticals Raises $21 Million In Series B Financing 5/13/2014
Gemmus Pharma Closes $3.3M Series B Funding To Develop Superior Flu Drug 5/13/2014
Nordic Nanovector: Conversion Of MNOK 25 Convertible Loan 5/13/2014
Lysosomal Therapeutics Inc. Receives $4.8 Million In Seed Funding 5/12/2014
Immunomedics, Inc. (IMMU) Closes $30 Million Public Offering Of Common Stock 5/8/2014
Lophius Biosciences GmbH Secures EUR 2,0 Million Financing And Announces Leadership Changes 5/8/2014
California's Arcadia Biosciences, Inc. Raises $33 Million Series D 5/8/2014
Gilead Sciences, Inc. (GILD) Will Buy Back Another $5 Billion Of Shares 5/8/2014
Livzon Mabpharm Leads $36 Million Funding Of Epirus, A U.S. Biosimilar Co. 5/7/2014
Celgene Corporation (CELG) Prices $2.5 Billion Of Senior Unsecured Notes 5/7/2014
Big Names Infuse Startup Anokion With $37.5 Million 5/7/2014
Connecticut Startup Loxo Oncology Reels In $24 Million Series B 5/6/2014
CryoTherapeutics GmbH Completes An Extension To Its Series A Financing Round Bringing The Total To EUR 6.5 Million 5/6/2014
BioTime (BTX) Raises $6.4 Million In Equity Financing 5/5/2014
Immunomedics, Inc. (IMMU) Prices $30 Million Public Offering Of Common Stock 5/2/2014
Newbie Lightstone Ventures Closes Life Sciences Fund At $172 Million 5/1/2014
Orexo AB (ORXOF) Issues A SEK 500 Million Bond Loan On The Swedish Bond Market 4/30/2014
Rich Pharmaceuticals Provides Financing Update 4/30/2014
IntelGenx Corp. Announces Government Of Canada Funding For CNS Versafilm™ Project 4/30/2014
Otonomy, Inc. Bags $49 Million To Advance Three Ear Disease Drugs 4/30/2014
InnaVirVax: Bpifrance Provides Funding For The PROTHEVIH Program On The Therapeutic Vaccine VAC-3S 4/29/2014
Sunshine Biopharma, Inc. Secures Funding For Its Adva-27a Anticancer Compound From Dutchess Opportunity Fund II 4/29/2014
Voluntis Raises € 20.75 Million ($ 29 Million) 4/28/2014
Verdezyne, Inc. Nabs $48 Million Financing 4/28/2014
Kite Pharma, Inc. Reels In $50 Million Private Financing 4/28/2014
Alimera Sciences (ALIM) Secures $35 Million Debt Facility 4/25/2014
Tauriga Sciences Inc. (TAUG) Aggregate Private Placement Proceeds Exceed $1,100,000 USD Priced At 6 Cents Per Share 4/24/2014
Isarna Therapeutics Raises Euro 5.5 Million, Announces Elizabeth Czerepak Joining As CFO/CBO To Lead U.S. Site 4/24/2014
Startup CRISPR Therapeutics Nabs $25 Million Series A , Forms A World-Renowned Team Of Academics And Clinicians 4/24/2014
Cancer-Fighter Juno Therapeutics Completes $176 Million Series A Round 4/24/2014
Two San Francisco Startups, Element Science And Nurix, Reap Cash From Third Rock Ventures' Rich Funding Round 4/24/2014
Aerpio Closes $22 Million Financing 4/23/2014
Neos Therapeutics Announces $20 Million Loan Facility And Updated Total Of $18 Million For Its Additional Series C Financing 4/23/2014
Massachusetts' Kala Pharmaceuticals Nabs $22.5 Million More For Eye Drugs 4/23/2014
Bay Area's Principia Biopharma Secures $50 Million Series B Financing 4/22/2014
Menlo Park's Avalanche Biotechnologies Secures $55 Million 4/22/2014
Pharming Group (PHGUF.PK) Announces ("Sub 10%") €14.7 Million Private Equity Placement With Institutional Investors 4/22/2014
ProNAi Therapeutics, Inc. Banks $59.5 Million Series D To Fund Non-Hodgkin's Lymphoma Studies 4/22/2014
DARA BioSciences, Inc. Files To Raise $32 Million For Specialty Pharma 4/21/2014
Oxford Finance And Midcap Financial Close $20 Million Senior Credit Facility With Zafgen 4/18/2014
UK Authortity To Spend £18.7 Million To Make Gilead Sciences, Inc. (GILD)'s Sovaldi Available To Most Grave Patients 4/18/2014
Johnson & Johnson (JNJ) Starts Construction On $300 Million China Plant 4/18/2014
VCs Wager $243 Million On San Diego Startups In Q1 4/18/2014
Nora Therapeutics Announces $18 Million Series B Financing 4/17/2014
Oxford Finance And Silicon Valley Bank Expand Existing Senior Credit Facility With Sorrento Therapeutics, Inc. To $12.5 Million 4/17/2014
CEL-SCI (CVM) Announces Closing Of Public Offering For Gross Proceeds Of $10 Million 4/17/2014
Startup Heart Metabolics Limited Launches With $20 Million In Pocket 4/17/2014
Orflo Raises $3.0 Million Of Growth Capital To Support Continued Expansion 4/17/2014
Wilson Therapeutics Bags $40 Million To Advance Late Stage Development Program For Wilson's Disease 4/16/2014
OxThera, Inc. Receives SEK 70 Million Financing To Continue Its Key Clinical Programs 4/16/2014
Nexvet Announces $31.5 Million Financing 4/16/2014
Iconic Therapeutics, Inc. Nabs $20 Million For Wet AMD Program 4/16/2014
Boston-Based EPIRUS Biopharmaceuticals Reels In $36 Million Series B, Will Merge With Zalicus Inc. (ZLCS) In All-Stock Deal 4/16/2014
Benitec Biopharma Wraps Up $29 Million+ Funding Round 4/15/2014
Startup AAVLife Emerges From Stealth Mode With $12 Million In Pocket 4/15/2014
New Jersey's PanOptica, Inc. Reels In $45 Million To Fund Development Of Wet AMD Eye Med 4/15/2014
New Jersey's Elite Pharmaceuticals, Inc. (ELI) Bags $40 Million 4/14/2014
CEL-SCI (CVM) Prices $10 Million Public Offering Of Common Stock And Six Month Warrants 4/14/2014
Spinifex Pharmaceuticals Bags $45 Million To Fund Pain Drug Trials, Established U.S. Base In Connecticut 4/11/2014
NuCana Hauls In $57 Million 4/11/2014
Northwest Biotherapeutics (NWBO) Scrounges Up $32 Million 4/10/2014
Assembly Pharmaceuticals And BioCrossroads Announce Investment To Advance Potentially Curative Therapy For Chronic Hepatitis B Virus 4/10/2014
Galapagos NV (GLPG.BR) Raises €2.4 Million Through Warrant Exercises 4/10/2014